Life AI Net
Home
Archive
Calculators
Directory
Login
中文
Auto
Home
Archive
Calculators
Directory
中文
Auto
Login
Home
Archive
Calculators
Directory
More
Live
Thermo Fisher
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan
FierceBiotech
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
BioWorld
Sex differences shape gene activity across the human brain
FierceBiotech
Rare Disease Research, myTomorrows team up to help patients access trials
FierceBiotech
Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
FierceBiotech
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
BioWorld
Financings for April 16, 2026
BioWorld
In the clinic for April 16, 2026
Thermo Fisher
Lobbying Update: $710,000 of THERMO FISHER SCIENTIFIC INC lobbying was just disclosed - Quiver Quantitative
10x Genomics Blog
Saxonov, 10x Genomics CEO, sells $122k in stock - Investing.com
10x Genomics Blog
10x Genomics (NASDAQ: TXG) CEO sells 5,000 shares in 10b5-1 trade - Stock Titan
FierceBiotech
RyghtAI launches clinical site search engine to aid drug developers, CROs with trial design
BioWorld
Sex differences shape gene activity across the human brain
FierceBiotech
Rare Disease Research, myTomorrows team up to help patients access trials
FierceBiotech
Aligos sells China rights to HBV drug to hepatology player Amoytop in $445M deal
FierceBiotech
Pfizer–backed Storm blows into $56M series C, launches phase 2 sarcoma trial
FierceBiotech
Johnson & Johnson hands back failed eye disease gene therapy to MeiraGTx
FierceBiotech
'Absent or trivial' effects: Anti-amyloid Alzheimer's drugs called into question once again
BioWorld
Financings for April 16, 2026
BioWorld
In the clinic for April 16, 2026
Archive
BioWorld
Apr 16, 2026
In the clinic for April 16, 2026
In the clinic for April 16, 2026
Original
Body unavailable. Use the original source.